Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

NL Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Portfolio companies 1
Rounds per year 0.10
Lead investments 0
Key employees Soon

Areas of investment

  • Analytics
  • Genetics
  • Biotechnology
  • Health Care
  • Medical
Summary

NL Ventures is the famous VC, which was founded in 2012. The main office of represented VC is situated in the Chicago. The company was established in North America in United States.

The usual things for fund are deals in the range of 1 - 5 millions dollars. The important activity for fund was in 2016. The fund is constantly included in less than 2 investment rounds annually.

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Sequence Bio. For fund there is no match between the location of its establishment and the land of its numerous investments - Canada. We can highlight the next thriving fund investment areas, such as Analytics, Biotechnology.

The typical case for the fund is to invest in rounds with 4 participants. Despite the NL Ventures, startups are often financed by Pelorus Venture Capital, Klister Credit, Killick Capital. The meaningful sponsors for the fund in investment in the same round are Klister Credit, Killick Capital, Data Collective DCVC.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Additio Investment Group Barcelona, Catalonia, Spain
Cactus Communications India, Maharashtra, Mumbai
Chase Manhattan Corporation Manhattan, New York, United States
Chengtai Xinxi China, Shanghai
Hargreave Hale Aim VCT England, London, United Kingdom
Haystack Australia, Brisbane, Queensland
Huaruixin China, Guangdong, Shenzhen
Kois -
Landis+Gyr Switzerland, Zug, Zug
Lanying Materials Trade China, Jiangsu, Suzhou
Lineage Logistics Michigan, Novi, United States
Medical Incubator Japan -
SBI Investment Korea Seoul, Seoul-t'ukpyolsi, South Korea
Shanghai Qianyi Investment Management China, Shanghai
Spring Capital Estonia, Harjumaa, Tallinn
Strategic Year Holdings China, Hong Kong, Hong Kong Island
UCSF Foundation Investment Company California, San Francisco, United States
Underdog Ventures Island Pond, United States, Vermont
Xpring California, San Francisco, United States
Yidezhen Touzi China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Sequence Bio

Analytics
Biotechnology
Genetics
Health Care
Medical
03 Aug 2016 St. John's, Newfoundland and Labrador, Canada

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent NL Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Rounds per year 0.10
Peak activity year 2016
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Sequence Bio

Analytics
Biotechnology
Genetics
Health Care
Medical
03 Aug 2016 St. John's, Newfoundland and Labrador, Canada
Crunchbase icon

Content report

The following text will be sent to our editors: